Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  TGFbDNRII-transduced autologous tumor-infiltrating lymphocytes
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients with Stage III-IV Melanoma
Phase: Phase I
Type: Treatment
Age: 7 and over
Trial IDs: 2012-0758, NCI-2014-01211, RM1012-012-1, RP110553-P4, NCT01955460
Start Over